19 agosto 2014
DNA sequencing of a lupus patient has identified a specific genetic mutation that is causing the disease, opening the way for personalized treatments. Researchers identified a variant in the TREX1 gene. This mutation caused the patient’s cells to produce a molecule called interferon-alpha. Clinical trials are already underway for drugs to target interferon-alpha in adults.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/Czx9TnSf1u0/140819113159.htm
